These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

665 related items for PubMed ID: 8666561

  • 1. An open-label trial of nefazodone in high comorbidity panic disorder.
    DeMartinis NA, Schweizer E, Rickels K.
    J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
    [Abstract] [Full Text] [Related]

  • 2. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
    Zajecka JM.
    J Clin Psychiatry; 1996 Jun; 57 Suppl 2():10-4. PubMed ID: 8626357
    [Abstract] [Full Text] [Related]

  • 3. Pilot open-label study of nefazodone in panic disorder.
    Bystritsky A, Rosen R, Suri R, Vapnik T.
    Depress Anxiety; 1999 Jun; 10(3):137-9. PubMed ID: 10604088
    [Abstract] [Full Text] [Related]

  • 4. Phenomenology and severity of major depression and comorbid lifetime anxiety disorders in primary medical care practice.
    Brown C, Schulberg HC, Shear MK.
    Anxiety; 1996 Jun; 2(5):210-8. PubMed ID: 9160625
    [Abstract] [Full Text] [Related]

  • 5. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
    Fawcett J, Marcus RN, Anton SF, O'Brien K, Schwiderski U.
    J Clin Psychiatry; 1995 Jun; 56 Suppl 6():37-42. PubMed ID: 7649972
    [Abstract] [Full Text] [Related]

  • 6. Mixed anxiety and depression in older adults: clinical characteristics and management.
    Cassidy EL, Lauderdale S, Sheikh JI.
    J Geriatr Psychiatry Neurol; 2005 Jun; 18(2):83-8. PubMed ID: 15911936
    [Abstract] [Full Text] [Related]

  • 7. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
    Baldwin DS, Hawley CJ, Abed RT, Maragakis BP, Cox J, Buckingham SA, Pover GH, Ascher A.
    J Clin Psychiatry; 1996 Jun; 57 Suppl 2():46-52. PubMed ID: 8626363
    [Abstract] [Full Text] [Related]

  • 8. An open trial of nefazodone in adult patients with generalized anxiety disorder.
    Hedges DW, Reimherr FW, Strong RE, Halls CH, Rust C.
    Psychopharmacol Bull; 1996 Jun; 32(4):671-6. PubMed ID: 8993090
    [Abstract] [Full Text] [Related]

  • 9. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
    Brady KT, Clary CM.
    Compr Psychiatry; 2003 Jun; 44(5):360-9. PubMed ID: 14505296
    [Abstract] [Full Text] [Related]

  • 10. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE, Franznick DA, Hollander SB, Fava M.
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [Abstract] [Full Text] [Related]

  • 11. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV, McElroy SL, Harnett-Sheehan K, Keck PE, Janavs J, Rogers J, Gonzalez R, Shivakumar G, Suppes T.
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nefazodone in the treatment of severe, melancholic, and recurrent depression.
    Marcus RN, Mendels J.
    J Clin Psychiatry; 1996 Jun; 57 Suppl 2():19-23. PubMed ID: 8626359
    [Abstract] [Full Text] [Related]

  • 15. Nefazodone therapy in patients with treatment-resistant or treatment-intolerant depression and high psychiatric comorbidity.
    Sajatovic M, DiGiovanni S, Fuller M, Belton J, DeVega E, Marqua S, Liebling D.
    Clin Ther; 1999 Apr; 21(4):733-40. PubMed ID: 10363738
    [Abstract] [Full Text] [Related]

  • 16. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.
    Depress Anxiety; 2007 Apr; 24(1):1-14. PubMed ID: 16894619
    [Abstract] [Full Text] [Related]

  • 17. Nefazodone for social phobia: a clinical case series.
    Worthington JJ, Zucker BG, Fones CS, Otto MW, Pollack MH.
    Depress Anxiety; 1998 Apr; 8(3):131-3. PubMed ID: 9836065
    [Abstract] [Full Text] [Related]

  • 18. Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy.
    Bakish D, Hooper CL, Thornton MD, Wiens A, Miller CA, Thibaudeau CA.
    Int Clin Psychopharmacol; 1997 Mar; 12(2):91-7. PubMed ID: 9219044
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer.
    Henry C, Van den Bulke D, Bellivier F, Etain B, Rouillon F, Leboyer M.
    J Clin Psychiatry; 2003 Mar; 64(3):331-5. PubMed ID: 12716276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.